GZMB and autoimmune disease: Patients on B cell depleting therapies for autoimmune diseases have been shown to have an altered immune response to vaccination, for example a lowered percentage of granzyme B+ CD8+ T cells in response to stimulation with the vaccine as compared to healthy controls (12).